Allopurinol for pain relief: More than just crystal clearance?

British Journal of Pharmacology

Volumn 156, Issue 1, 2009, Pages 4-6

  Connor, Mark ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Adenosine; Allopurinol; Analgesia; Anti nociception; Mouse; Xanthine oxidase

Indexed keywords

5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE KINASE; ALLOPURINOL; CAPSAICIN; FEBUXOSTAT; GLUTAMIC ACID; HYPOXANTHINE; REACTIVE OXYGEN METABOLITE; URIC ACID; XANTHINE OXIDASE; ANALGESIC AGENT;

ANALGESIA; ANTINOCICEPTION; CHRONIC INFLAMMATION; DIABETIC NEUROPATHY; ENDOTHELIAL DYSFUNCTION; ENZYME INHIBITION; GOUT; HUMAN; MOUSE; NONHUMAN; NOTE; OXIDATIVE STRESS; PAIN; PRIORITY JOURNAL; PURINE METABOLISM; REPERFUSION INJURY; SICKLE CELL ANEMIA; ANIMAL; CEREBROSPINAL FLUID; DRUG ANTAGONISM; DRUG POTENTIATION; METABOLISM;

ADENOSINE; ALLOPURINOL; ANALGESICS; ANIMALS; GOUT; MICE; PAIN; REACTIVE OXYGEN SPECIES; RECEPTOR, ADENOSINE A1; XANTHINE OXIDASE;

EID: 65549120707     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2008.00065.x     Document Type: Note

References (11)

1. Banks PA, Hughes M, Ferrante M, Noordheok EC, Ramagopal V, Slivka A (1997). Does allopurinol reduce the pain of chronic pancreatitis Int J Pancreatol 22 : 171 176.
2. Bruce SP (2006). Febuxostat: a selective xanthine oxidase inhibitor for the treatment of hyperuricemia and gout. Ann Pharmacother 40 : 2187 2193.
3. Elion GB, Callahan S, Nathan H, Bieber S, Rundles RW, Hitchings GH (1963). Potentiation by inhibition of drug degradation: 6-substituted purines and xanthine oxidase. Biochem Pharmacol 12 : 85 93.
4. Inkster ME, Cotter MA, Cameron NE (2007). Treatment with xanthine oxidase inhibitor, allopurinol, improves nerve and vascular function in diabetic rats. Eur J Pharmacol 561 : 63 71.
5. Jarvis MF, Yu H, McGaraughty S, Wismer CT, Mikusa J, Zhu et al. (2002). Analgesic and anti-inflammatory effects of A-286501, a novel orally active adenosine kinase inhibitor. Pain 96 : 107 118.
6. Pacher P, Nivorozhkin A, Szabo C (2006). Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol Rev 58 : 87 114.
7. Salim AS (1991). Role of reactive oxygen-derived free radical scavengers in the treatment of recurrent pain produced by chronic pancreatitis. A new approach. Arch Surg 126 : 1109 1114.
8. Sawynok J, Liu XJ (2003). Adenosine in the spinal cord and periphery: release and regulation of pain. Prog Neurobiol 69 : 313 340.
9. 1 receptors. Br J Pharmacol 156 : 161 170.
10. Takano Y, Hase-Aoki K, Horiuchi H, Zhao L, Kasahara Y, Kondo S et al. (2005). Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase/xanthine dehydrogenase. Life Sci 76 : 1835 1847.
11. Wood KC, Granger DN (2007). Sickle cell disease: role of reactive oxygen species and nitrogen metabolites. Clin Exp Pharmacol Physiol 34 : 926 932.